In fact, at this point, it is not possible to discern whether CX3CL1 signature would be cause or consequence in HB tumorigenesis, and this provides a starting point for future studies aiming to investigate if the activation of this pathway could be raised by the chemotherapy treatment. Here, CX3CL1 is linked to hemoglobin measurement.